Point of Care Diagnostics Market worth $72.0 billion by 2027 – Exclusive Report by MarketsandMarkets™

Point of Care & Rapid Diagnostics Market
The Point of Care Diagnostics Market growth of the global Point of Care diagnostics market can be attributed to factors such as increasing prevalence of respiratory diseases (such as COVID-19 and influenza) across the globe, and improved access to point-of-care devices through online platforms are some of the other key factors likely to drive the long-term growth. High prevalence of infectious...

Roche Diagnostics (Switzerland) and Danaher Corporation (US) are Leading Players in Point of Care Diagnostics Market

Point of Care/Rapid Diagnostics Market
Market Overview: The global point-of-care diagnostics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4% during the forecast period. Factors such as the growing increase in the prevalence of infectious diseases globally, extensive focius on research and development activities, rising level of healthcare decentralization in several...

Point-of-Care Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges

The global Point-of-Care Diagnostics market is projected to reach USD 38.13 Billion by 2022 from USD 23.71 Billion in 2017, at a CAGR of 10.0% during the forecast period. The report covers the Point-of-Care Diagnostics market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share of the Rapid...